(Reuters) - The EU's drug regulator on Thursday approved the use of Pfizer-BioNTech's COVID-19 vaccine for children between the ages of five and 11, opening the way for them to be given a first shot as Europe battles surging infections.

       (Reporting by Pushkala Aripaka in Bengaluru; Editing by Josephine Mason and Alexander Smith)